Dec 2016 $1 M Private placement after listing Under $2 million 7
Pure Bioscience: Private sale, Dec 2016 × Investors in this round 7 investors had bought by the notice of Dec 15, 2016: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $25,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions $122,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Mark Y. Elliott · Executive Officer David R. Theno, Jr. · Director Gary R. Cohee · Director Tom Y. Lee · Director William R. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Garden State Securities, Inc. (CRD 10083) · Red Bank, New Jersey Sold in AZ, ID, IL, NJ Signed by Mark Elliott, Vice President, Finance. Source: SEC Form D, newest notice filed Dec 15, 2016. Read the notice at the SEC .
equity, options SEC Nov 2015 $2 M Private placement after listing $2 to $10 million 13
Pure Bioscience: Private sale, Nov 2015 × Investors in this round 13 investors had bought by the notice of Dec 7, 2015: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Mark Y. Elliott · Executive Officer David R. Theno, Jr. · Director Gary R. Cohee · Director Tom Y. Lee · Director William R. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Elliott, Vice President, Finance. Source: SEC Form D, newest notice filed Dec 7, 2015. Read the notice at the SEC .
equity, options SEC Oct 2015 $6 M Private placement after listing $2 to $10 million 1
Pure Bioscience: Private sale, Oct 2015 × Investors in this round 1 investor had bought by the notice of Oct 30, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Henry R. Lambert · Executive Officer, Director Mark Y. Elliott · Executive Officer Dave R. Pfanzelter · Director David R. Theno, Jr. · Director Gary R. Cohee · Director Tom Y. Lee · Director William R. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Elliott, Vice President, Finance. Source: SEC Form D, newest notice filed Oct 30, 2015. Read the notice at the SEC .
equity, options SEC Aug 2014 $10 M Private placement after listing $2 to $10 million 28
Pure Bioscience: Private sale, Aug 2014 × Investors in this round 28 investors had bought by the notice of Sep 4, 2014: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Henry R. Lambert · Executive Officer, Director Peter C. Wulff · Executive Officer Dave R. Pfanzelter · Director David R. Theno, Jr. · Director Gary R. Cohee · Director William R. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Wulff, CFO and COO. Source: SEC Form D, newest notice filed Sep 4, 2014. Read the notice at the SEC .
equity, options SEC Jan 2014 $1 M Private placement after listing Under $2 million 15
Pure Bioscience: Private sale, Jan 2014 × Investors in this round 15 investors had bought by the notice of Mar 14, 2014: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $5 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Peter C. Wulff · Executive Officer Craig C. Culver · Director David R. Theno, Jr. · Director Gary R. Cohee · Director William C. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Wulff, CFO and COO. Source: SEC Form D, newest notice filed Mar 14, 2014. Read the notice at the SEC .
equity SEC Dec 2013 $1 M No. 4 Under $2 million 8
Pure Bioscience: Raise no. 4, Dec 2013 × Investors in this round 8 investors had bought by the notice of Dec 19, 2013: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Peter C. Wulff · Executive Officer Craig C. Culver · Director David R. Theno, Jr. · Director Gary R. Cohee · Director William C. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Wulff, CFO and COO. Source: SEC Form D, newest notice filed Dec 19, 2013. Read the notice at the SEC .
equity SEC Oct 2013 $2 M No. 3 $2 to $10 million 40
Pure Bioscience: Raise no. 3, Oct 2013 × Investors in this round 40 investors had bought by the notice of Dec 17, 2013: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Peter C. Wulff · Executive Officer Craig C. Culver · Director David R. Theno, Jr. · Director Gary R. Cohee · Director William C. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Wulff, CFO and COO. Source: SEC Form D, newest notice filed Dec 17, 2013. Read the notice at the SEC .
equity SEC Aug 2013 $1 M No. 2 Under $2 million 22
Pure Bioscience: Raise no. 2, Aug 2013 × Investors in this round 22 investors had bought by the notice of Dec 16, 2013: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dave R. Pfanzelter · Executive Officer, Director Henry R. Lambert · Executive Officer, Director Peter C. Wulff · Executive Officer Craig C. Culver · Director David R. Theno, Jr. · Director Gary R. Cohee · Director William C. Otis · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Wulff, CFO and COO. Source: SEC Form D, newest notice filed Dec 16, 2013. Read the notice at the SEC .
equity SEC Oct 2010 $2 M No. 1 $2 to $10 million 11
Pure Bioscience: Raise no. 1, Oct 2010 × Investors in this round 11 investors had bought by the notice of Nov 9, 2010: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Andrew L. Buckland · Executive Officer Donna L. Singer · Executive Officer, Director Michael L. Krall · Executive Officer, Director Dennis L. Brovarone · Director Gregory H. Barnhill · Director John J. Carbone, MD · Director Paul V. Maier · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Andrew Buckland, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 9, 2010. Read the notice at the SEC .
equity SEC